Present Status of the Ehrlich Aldehyde Reaction for Urinary Porphobilinogen
- 9 November 1964
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 190 (6) , 501-504
- https://doi.org/10.1001/jama.1964.03070190021004
Abstract
The Watson-Schwartz test for urinary porphobilinogen (PBG) is generally characteristic for acute intermittent porphyria in relapse. The reaction is strong and unmistakable in patients with nervous or abdominal manifestations of the disease. Faint or borderline positive tests may be encountered in nonporphyric conditions, causing confusion in diagnosis. The additional use of butanol, which extracts all of the known Ehrlich aldehyde compounds except that of PBG, prevents such confusion. Pseudo-Ehrlich reactions, due to the hydrochloric acid in the reagent, are given by a number of compounds, including certain melanogens. A control with 22% hydrochloric acid must be carried out with each test.Keywords
This publication has 5 references indexed in Scilit:
- An Evaluation of a Recent Modification of the Watson-Schwartz Test for PorphobilinogenAnnals of Internal Medicine, 1964
- A Genetic Study of Two Families Having the Acute Intermittent Type of PorphyriaAnnals of Internal Medicine, 1961
- Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseasesNeurology, 1959
- OCCURRENCE AND DETERMINATION OF DELTA-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINE1956
- PORPHOBILINOGEN TESTS ON A THOUSAND MISCELLANEOUS PATIENTS IN A SEARCH FOR FALSE POSITIVE REACTIONS1948